---
schema_version: "secwatch.filing_event.v1"
accession: "0001372514-24-000057"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:30:25.351887+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Kiora Pharmaceuticals announces 1-for-9 reverse stock split effective June 11, 2024 to meet Nasdaq bid price requirement

## Summary
- 1-for-9 reverse stock split filed June 6, 2024; effective at open of market on June 11, 2024.
- Outstanding shares will reduce from ~26.7M to ~2.97M; fully diluted from ~100.1M to ~11.1M.
- Class D warrants for 3.43M shares expired on June 6, 2024; other warrants adjust proportionally.
- No change to authorized shares, par value ($0.01), or ticker (KPRX); fractional shares paid in cash.
- Reverse split is intended to maintain compliance with Nasdaq minimum bid price requirement.

## SEC filing metadata
- accession: 0001372514-24-000057
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000057/0001372514-24-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000057/kprx-20240606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001372514-24-000057
- JSON: https://secwatch.observer/filing/0001372514-24-000057.json
- Plain text: https://secwatch.observer/filing/0001372514-24-000057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.